2,281 results on '"Nonomura, Norio"'
Search Results
2. Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution
3. Prediction of undetectable circulating tumor DNA by comprehensive genomic profiling assay in metastatic prostate cancer: the SCRUM-Japan MONSTAR SCREEN project
4. Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management
5. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
6. Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project
7. Detection support of lesions in patients with prostate cancer using 18F-PSMA 1007 PET/CT
8. Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors
9. Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
10. Surgical resection of primary leiomyosarcoma of retro-hepatic inferior vena cava extending from bilateral renal veins across the diaphragm
11. The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer
12. Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study
13. Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
14. Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients
15. D-Asparagine is an Ideal Endogenous Molecule for Measuring the Glomerular Filtration Rate
16. A Case Report of a Kidney Transplant Recipient With Organizing Pneumonia After Graft Loss
17. EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer
18. Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study
19. Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study
20. A case of malignant pheochromocytoma with neurofibromatosis type 1 having difficulty in differentiating spinal tumor
21. MP15-04 EIF2S1 IN URINARY EXTRACELLULAR VESICLES AS A NOVEL DIAGNOSTIC MARKER FOR BLADDER CANCER
22. MP05-07 GDF15 PROPEPTIDE IS A NOVEL BLOOD BIOMARKER FOR CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASIS VIA PROMOTING THE VICIOUS CYCLE
23. MP59-03 EXERCISE IMPROVES NOCTURNAL POLYURIA VIA AN INCREASE IN NITRIC OXIDE PRODUCTION AND SUPPRESSION OF INTRARENAL RENIN-ANGIOTENSIN SYSTEM ACTIVITY IN AGED MICE
24. PD35-03 GENOME-WIDE CRISPR SCREENS IDENTIFIED THAT DCLRE1C REGULATES THE RADIOSENSITIVITY OF PROSTATE CANCER
25. MP41-05 LIQUID-BIOPSY BASED NOVEL mRNA GENOMIC TEST FOR EARLY DETECTION, PROGNOSIS AND MONITORING OF PROSTATE CANCER: A MULTICENTER STUDY
26. PD56-02 ORAL ADMINISTRATION OF SILICON-BASED AGENTS AMELIORATE RENAL FIBROSIS BY SUPPRESSING OXIDATIVE STRESS AND COMPLEMENT ACTIVITY
27. MP05-19 POLYGENETIC RISK SCORE FOR PROSTATE CANCER IS ASSOCIATED WITH LIPOPOLYSACCHARIDE PATHWAY IN GUT MICROBIOME
28. Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
29. Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
30. Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer
31. Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
32. Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
33. Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
34. Successful separation of male pygopagus with anal canal and urethral reconstruction: a case report
35. IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation
36. Current issues and management consensus of advanced prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference—JAPAN 2023.
37. Cutibacterium acnes‐derived extracellular vesicles promote tumor growth in renal cell carcinoma.
38. Measurement of glomerular filtration rate using endogenous d-serine clearance in living kidney transplant donors and recipients
39. Cumulative Incidence and Risk Factors for Anti-Resorptive Agent-Related Osteonecrosis of the Jaw during Long-Term Prostate Cancer Management
40. Remarkable Improvement of Diabetic Nephropathy in Transplanted Allograft after Kidney Transplantation
41. Fatal tumoral hemorrhage from brain metastases of renal cell carcinoma after stereotactic radiotherapy and immune checkpoint inhibitor and vascular endothelial growth factor‐targeted therapy combinations
42. GDF15 PROPEPTIDE IS A NOVEL BLOOD BIOMARKER OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER BY ENHANCING THE VICIOUS CYCLE OF BONE METASTASIS
43. ALANINE RESTRICTION CAN INHIBIT CARCINOGENESIS IN A NOVEL MOUSE MODEL OF UPPER TRACT UROTHELIAL CARCINOMA
44. A retroperitoneal primary undifferentiated pleomorphic sarcoma
45. Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer
46. Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma
47. Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study
48. The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study
49. High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients
50. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.